Comparable stake leader
LILLY ENDOWMENT INC
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0000059478.
Comparable stake leader
LILLY ENDOWMENT INC
Disclosed value leader
LILLY ENDOWMENT INC
Comparable rows
50/50
Latest evidence
17 Aug 2026
Ownership snapshot
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Quick read
50 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| LILLY ENDOWMENT INC |
13F
13D/G
3/4/5
Company · Former 10% Shareholder
|
9.6%
from 13D/G
|
$108,400,858,723
90,376,978 shares
|
— | 30 Jun 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC |
13F
13D/G
Company · Vanguard Capital Management
|
6.5%
from 13D/G
|
$64,204,130,146
53,528,868 shares
|
— | 30 Jun 2026 |
| PNC FINANCIAL SERVICES GROUP, INC. |
13F
13D/G
Company · THE PNC FINANCIAL SERVICES GROUP, INC.
|
5.4%
from 13D/G
|
$61,558,009,786
51,322,720 shares
|
— | 30 Jun 2026 |
| David A. Ricks |
3/4/5
President, Chair, and CEO, Director
|
0.08%
|
$772,300,676
708,781 shares
mixed-class rows
|
— | 09 Feb 2026 |
| Daniel Skovronsky |
3/4/5
EVP, CS&PO & Pres. LRL
|
0.03%
|
$259,506,003
235,688 shares
mixed-class rows
|
— | 09 Feb 2026 |
| J. Erik Fyrwald |
3/4/5
Director
|
0.01%
|
$90,458,761
75,418 shares
|
— | 17 Aug 2026 |
| Ralph Alvarez |
3/4/5
Director
|
0.01%
|
$67,771,138
56,503 shares
|
— | 17 Aug 2026 |
| Patrik Jonsson |
3/4/5
EVP & President, LLY Int'l
|
0.01%
|
$67,800,910
54,779 shares
mixed-class rows
|
-$7,638,150 | 17 Aug 2026 |
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Net insider flow leans to selling over the last 12 months. Net value: -$3,572,143,125.
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 16,000 | $0 | $18,835,095 | -$18,835,095 |
| 3-6 | 0 | 15,828 | $0 | $15,754,537 | -$15,754,537 |
| 6-9 | 0 | 300,000 | $0 | $330,900,755 | -$330,900,755 |
| 9-12 | 0 | 3,467,525 | $0 | $3,206,652,738 | -$3,206,652,738 |
Reporting owners
Showing 1-20 of 39 reporting-owner rows connected to ELI LILLY & Co. Open a relationship link for the CIK-to-CIK filing trail.
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| LILLY ENDOWMENT INC | Former 10% Shareholder | $91,530,439,650 | -$3,552,297,530 | -3.7% | Filing P/S | 06 May 2026 |
| David A. Ricks | President, Chair, and CEO, Director | $772,300,676 | Mixed | 09 Feb 2026 | ||
| Daniel Skovronsky | EVP, CS&PO & Pres. LRL | $259,506,003 | Mixed | 09 Feb 2026 | ||
| Stephen F. Fry | SVP, HR & Diversity | $101,263,226 | Mixed | 09 Feb 2022 | ||
| J. Erik Fyrwald | Director | $90,458,761 | Median | 17 Aug 2026 | ||
| Anne E. White | EVP & Pres, Lilly Neuroscience | $69,993,126 | Mixed | 10 Feb 2025 | ||
| Patrik Jonsson | EVP & President, LLY Int'l | $67,800,910 | -$7,638,150 | -10% | Mixed | 17 Aug 2026 |
| Ralph Alvarez | Director | $67,771,138 | Median | 17 Aug 2026 | ||
| Anat Hakim | EVP, GC & Secretary | $66,355,123 | -$5,950,000 | -8.2% | Mixed | 07 Aug 2026 |
| Edgardo Hernandez | EVP & Pres., Mfg. Operations | $49,091,234 | Mixed | 09 Feb 2026 | ||
| Jacob van Naarden | EVP,Pres LLY Oncology&HdCorpBD | $41,749,475 | Mixed | 09 Feb 2026 | ||
| Jackson Peter Tai | Director | $40,310,425 | Mixed | 17 Apr 2023 | ||
| Ilya Yuffa | EVP&Pres, LLY USA&Global Capab | $37,246,655 | -$2,876,925 | -7.2% | Mixed | 10 Jun 2026 |
| Anat Ashkenazi | Evp & Cfo | $34,963,818 | Mixed | 12 Feb 2024 | ||
| Diogo Rau | Evp & Cido | $30,835,705 | Mixed | 09 Feb 2026 | ||
| Michael L. Eskew | Director | $28,606,416 | Mixed | 15 Nov 2021 | ||
| Michael B. Mason | EVP & Pres., Lilly Diabetes | $27,598,461 | Mixed | 10 Feb 2023 | ||
| Katherine Baicker | Director | $24,012,635 | Mixed | 17 Nov 2025 | ||
| Johna Norton | EVP, Global Quality | $23,684,106 | Mixed | 03 Jun 2024 | ||
| William G. Kaelin Jr. | Director | $22,310,672 | Mixed | 17 Nov 2025 |
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Gabrielle Sulzberger | LLY | Common Stock | Award | 0.14% | 4.19 | 3,004 | 17 Aug 2026 | Direct | ||
| Juan R. Luciano | LLY | Common Stock | Award | 0.08% | 13.45 | 16,918 | 17 Aug 2026 | Direct | ||
| J. Erik Fyrwald | LLY | Common Stock | Award | 0.01% | 8.38 | 75,418 | 17 Aug 2026 | Direct | ||
| Ralph Alvarez | LLY | Common Stock | Award | 0.02% | 10.49 | 55,745 | 17 Aug 2026 | Direct | ||
| Patrik Jonsson | LLY | Common Stock | Sale | -10.7% | $7,638,150 | $1175.10 | -6,500 | 54,147 | 17 Aug 2026 | Direct |
| Donald A. Zakrowski | LLY | Common Stock | Sale | -56.7% | $2,370,020 | $1185.01 | -2,000 | 1,526 | 10 Aug 2026 | Direct |
| Anat Hakim | LLY | Common Stock | Sale | -29.6% | $5,950,000 | $1190.00 | -5,000 | 11,875 | 07 Aug 2026 | By spouse |
| Melissa Seymour | LLY | Common Stock | Tax liability | -29.1% | -439 | 1,067 | 01 Aug 2026 | Direct | ||
| Melissa Seymour | LLY | Common Stock | Options Exercise | 186.8% | 981 | 1,506 | 01 Aug 2026 | Direct | ||
| Melissa Seymour | LLY | Restricted Stock Unit | Options Exercise | -50.8% | -981 | 952 | 01 Aug 2026 | Direct | ||
| Gabrielle Sulzberger | LLY | Common Stock | Award | 0.14% | 4.32 | 3,000 | 20 Jul 2026 | Direct | ||
| Juan R. Luciano | LLY | Common Stock | Award | 0.08% | 13.88 | 16,905 | 20 Jul 2026 | Direct | ||
| J. Erik Fyrwald | LLY | Common Stock | Award | 0.01% | 8.65 | 75,410 | 20 Jul 2026 | Direct | ||
| Ralph Alvarez | LLY | Common Stock | Award | 0.02% | 10.83 | 55,734 | 20 Jul 2026 | Direct | ||
| Gabrielle Sulzberger | LLY | Common Stock | Award | 0.15% | 4.39 | 2,995 | 15 Jun 2026 | Direct | ||
| Juan R. Luciano | LLY | Common Stock | Award | 0.08% | 14.09 | 16,891 | 15 Jun 2026 | Direct | ||
| J. Erik Fyrwald | LLY | Common Stock | Award | 0.01% | 8.78 | 75,401 | 15 Jun 2026 | Direct | ||
| Ralph Alvarez | LLY | Common Stock | Award | 0.02% | 10.99 | 55,723 | 15 Jun 2026 | Direct | ||
| Ilya Yuffa | LLY | Common Stock | Sale | -7.74% | $2,876,925 | $1150.77 | -2,500 | 29,804 | 10 Jun 2026 | Direct |
| Gabrielle Sulzberger | LLY | Common Stock | Award | 0.17% | 5.02 | 2,987 | 18 May 2026 | Direct | ||
| Juan R. Luciano | LLY | Common Stock | Award | 0.1% | 16.11 | 16,851 | 18 May 2026 | Direct | ||
| J. Erik Fyrwald | LLY | Common Stock | Award | 0.01% | 10.04 | 75,280 | 18 May 2026 | Direct | ||
| Ralph Alvarez | LLY | Common Stock | Award | 0.02% | 12.57 | 55,627 | 18 May 2026 | Direct | ||
| Lilly Endowment Inc | LLY | Common Stock | Sale | -0.02% | $15,754,537 | $995.36 | -15,828 | 91,881,150 | 06 May 2026 | Direct |
| Gabrielle Sulzberger | LLY | Common Stock | Award | 0.18% | 5.39 | 2,982 | 20 Apr 2026 | Direct | ||
| Juan R. Luciano | LLY | Common Stock | Award | 0.1% | 17.3 | 16,835 | 20 Apr 2026 | Direct | ||
| J. Erik Fyrwald | LLY | Common Stock | Award | 0.01% | 10.78 | 75,270 | 20 Apr 2026 | Direct | ||
| Ralph Alvarez | LLY | Common Stock | Award | 0.02% | 13.5 | 55,615 | 20 Apr 2026 | Direct | ||
| Gabrielle Sulzberger | LLY | Common Stock | Award | 0.17% | 5.01 | 2,976 | 16 Mar 2026 | Direct | ||
| Juan R. Luciano | LLY | Common Stock | Award | 0.1% | 16.09 | 16,817 | 16 Mar 2026 | Direct | ||
| J. Erik Fyrwald | LLY | Common Stock | Award | 0.01% | 10.03 | 75,259 | 16 Mar 2026 | Direct | ||
| Ralph Alvarez | LLY | Common Stock | Award | 0.02% | 12.55 | 55,601 | 16 Mar 2026 | Direct | ||
| Eric Dozier | LLY | Common Stock | Gift | -3.22% | -481 | 14,455 | 19 Feb 2026 | Direct | ||
| Gabrielle Sulzberger | LLY | Common Stock | Award | 0.16% | 4.79 | 2,966 | 17 Feb 2026 | Direct | ||
| Juan R. Luciano | LLY | Common Stock | Award | 0.09% | 15.36 | 16,772 | 17 Feb 2026 | Direct | ||
| J. Erik Fyrwald | LLY | Common Stock | Award | 0.01% | 9.57 | 75,120 | 17 Feb 2026 | Direct | ||
| Ralph Alvarez | LLY | Common Stock | Award | 0.02% | 11.99 | 55,492 | 17 Feb 2026 | Direct | ||
| Donald A. Zakrowski | LLY | Common Stock | Tax liability | -2.26% | -81.55 | 3,526 | 16 Feb 2026 | Direct | ||
| Donald A. Zakrowski | LLY | Common Stock | Options Exercise | 5.37% | 184 | 3,607 | 16 Feb 2026 | Direct | ||
| Donald A. Zakrowski | LLY | Restricted Stock Unit | Options Exercise | -100% | -184 | 0 | 16 Feb 2026 | Direct | ||
| Lucas Montarce | LLY | Common Stock | Tax liability | -0.97% | -160 | 16,258 | 16 Feb 2026 | Direct | ||
| Lucas Montarce | LLY | Common Stock | Options Exercise | 2.29% | 368 | 16,418 | 16 Feb 2026 | Direct | ||
| Lucas Montarce | LLY | Restricted Stock Unit | Options Exercise | -100% | -368 | 0 | 16 Feb 2026 | Direct | ||
| Kenneth L. Custer | LLY | Common Stock | Tax liability | -0.89% | -91.31 | 10,141 | 16 Feb 2026 | Direct | ||
| Kenneth L. Custer | LLY | Common Stock | Options Exercise | 2.06% | 207 | 10,232 | 16 Feb 2026 | Direct | ||
| Kenneth L. Custer | LLY | Restricted Stock Unit | Options Exercise | -100% | -207 | 0 | 16 Feb 2026 | Direct | ||
| Adrienne S. Brown | LLY | Common Stock | Tax liability | -3.2% | -170 | 5,142 | 16 Feb 2026 | Direct | ||
| Adrienne S. Brown | LLY | Common Stock | Options Exercise | 7.95% | 391 | 5,312 | 16 Feb 2026 | Direct | ||
| Adrienne S. Brown | LLY | Restricted Stock Unit | Options Exercise | -100% | -391 | 0 | 16 Feb 2026 | Direct | ||
| Diogo Rau | LLY | Common Stock | Award | 21.1% | 4,599 | 26,397 | 09 Feb 2026 | Direct |